1. Vaccination with RSV M
- Author
-
Tiago, Fazolo, Rodrigo Benedetti, Gassen, Deise Nascimento, de Freitas, Thiago J, Borges, Maurício Menegatti, Rigo, Rodrigo Dornelles, da Silva, Fábio, Maito, Aline, Cunha, Daniel Augusto, Gasparin Bueno Mendes, André, Báfica, José Eduardo, Vargas, Ana Paula Duarte, de Souza, and Cristina, Bonorino
- Subjects
CD4-Positive T-Lymphocytes ,Vaccines, Synthetic ,Histocytochemistry ,Viral Vaccines ,Pneumonia ,Respiratory Syncytial Virus Infections ,Th1 Cells ,T-Lymphocytes, Regulatory ,Interleukin-10 ,Respiratory Syncytial Viruses ,Mice, Inbred C57BL ,Viral Matrix Proteins ,Disease Models, Animal ,Interferon-gamma ,Th2 Cells ,Treatment Outcome ,Chlorocebus aethiops ,Vaccines, Subunit ,Animals ,Lung ,Oligopeptides ,Vero Cells - Abstract
Respiratory syncytial virus (RSV) is the most common etiologic agent in severe infections of the lower respiratory tract in children with a high mortality rate. However, there are still no licensed vaccines for RSV. In this study, we investigated a putative vaccine based on M
- Published
- 2018